"It was widely anticipated that this drug would be approved. Many people felt it was almost certain.... But the FDA has become increasingly more vigilant recently about approving drugs before the full safety data have been evaluated. It is still burned about the Vioxx scandal."
Last 14 days









HeartBeat

